Vaginal Health Solution
Nucleic Acid Amplification Test (NAAT) technology delivering excellent sensitivity and specificity for multiple pathogens in symptomatic women in just one vaginal swab.1,2

Report Clear Objective Results & Improve Workflow
Objective tools for the clinician to accurately diagnose and treat patients with symptoms associated with vaginitis1,2. Benefit from superior workflow, reduced hands-on time and sample volume scalability from running assays on the fully-automated Panther® System.3
Proven Performance
95%
sensitivity1
Bacterial Vaginosis
clinician-collected sample
91.7%
sensitivity2
Candida species
clinician-collected sample
84.7%
sensitivity2
Candida glabrata
clinician-collected sample
96.5%
sensitivity2
TV
clinician-collected sample
Sample-to-result within a Single Integrated Instrument

Aptima® CV/TV assay
The Aptima CV/TV assay is a NAAT that helps to detect one of the most common causes of infectious vaginitis: Candida vaginitis (CV) and trichomoniasis (TV). Targets include the Candida species group (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata and Trichomonas vaginalis.2

Panther® Scalable Solution
The Hologic high-throughput solution allows you to expand your testing menu while adding flexibility, capacity and walkaway time. The Panther® System is the foundation of Panther Scalable Solutions. It lets you customise your testing by choosing from a broad assay menu and instrument add-ons, allowing an economical and scalable path to your growth.
Simplify & Scale the Future of Diagnostics
The Vaginal Health Solution is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single patient rapid result to population-level screening.

Scale Your Operation
Explore how the Panther System helps you optimise today and prepare for tomorrow. The fully-automated system loads samples in any order at any time, eliminates batch constraints and decreases turnaround time.
- Aptima BV Assay [Package Insert] AW-23712-001 Rev.001. San Diego, CA; Hologic, Inc., 2022.
- Aptima CV/TV Assay [package insert] AW-23713-001 Rev. 004. San Diego, CA; Hologic, Inc., 2023
- Ratnam S, Jang D, Gilchrist J et.al. Workflow and Maintenance Characteristics of Five Automated Laboratory Instruments for the Diagnosis of Sexually Transmitted Infections. J. Clin. Microbiol. 2014;52(7):2299-2304
Related Portfolios & Solutions

Molecular Scalable Solution
A scalable portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient rapid result to population level screening.

Cervical Health
We offer a comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. Our leading technologies provide effective, robust and proven end-to-end solutions that meet the needs of all commonly used national cervical cancer screening programs.
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body Number wherever applicable